Literature DB >> 17999717

Complex I specific increase in superoxide formation and respiration rate by PrP-null mouse brain mitochondria.

Andrew W J Paterson1, John C Curtis, Nikki K Macleod.   

Abstract

An imbalance in free radical production and removal is considered by many to be an important factor in the etiology of many degenerative diseases. Since mitochondria are a major source of free radicals, we have examined mitochondrial free radical production in relation to oxidative phosphorylation in PrP-null mice. Quantitative electron paramagnetic resonance spectroscopy revealed up to a 70% increase in superoxide production from Complex I of submitochondrial particles prepared from PrP-null mice. This was accompanied by elevated respiratory capacity through Complex I without any discernible alteration in respiratory efficiency. These differences are associated with changes in superoxide dismutase levels and defects in mitochondrial morphology, confirming previously reported results. Our results demonstrate a clear difference in free radical production and oxygen consumption by mitochondrial Complex I between PrP-null mice and wild-type controls, pointing to Complex I as a potential target for pathological change, suggesting similarities between prion-related and other neurodegenerative diseases.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17999717     DOI: 10.1111/j.1471-4159.2007.05123.x

Source DB:  PubMed          Journal:  J Neurochem        ISSN: 0022-3042            Impact factor:   5.372


  9 in total

1.  Morphological and functional abnormalities in mitochondria associated with synaptic degeneration in prion disease.

Authors:  Zuzana Sisková; Don Joseph Mahad; Carianne Pudney; Graham Campbell; Mark Cadogan; Ayodeji Asuni; Vincent O'Connor; Victor Hugh Perry
Journal:  Am J Pathol       Date:  2010-07-22       Impact factor: 4.307

2.  Cellular prion protein dysfunction in a prototypical inherited metabolic myopathy.

Authors:  Sophie Mouillet-Richard; Fatima Djouadi; Fatima-Zohra Boufroura; Céline Tomkiewicz-Raulet; Virginie Poindessous; Johan Castille; Jean-Luc Vilotte; Jean Bastin
Journal:  Cell Mol Life Sci       Date:  2020-09-01       Impact factor: 9.261

Review 3.  Physiological Functions of the Cellular Prion Protein.

Authors:  Andrew R Castle; Andrew C Gill
Journal:  Front Mol Biosci       Date:  2017-04-06

4.  Melatonin protects mesenchymal stem cells from autophagy-mediated death under ischaemic ER-stress conditions by increasing prion protein expression.

Authors:  Jun Hee Lee; Yeo Min Yoon; Yong-Seok Han; Seo Kyung Jung; Sang Hun Lee
Journal:  Cell Prolif       Date:  2018-11-14       Impact factor: 6.831

5.  Hereditary E200K mutation within the prion protein gene alters human iPSC derived cardiomyocyte function.

Authors:  Aleksandar R Wood; Simote T Foliaki; Bradley R Groveman; Ryan O Walters; Katie Williams; Jue Yuan; Wen-Quan Zou; Cathryn L Haigh
Journal:  Sci Rep       Date:  2022-09-22       Impact factor: 4.996

6.  Inherited mtDNA variations are not strong risk factors in human prion disease.

Authors:  Gavin Hudson; James Uphill; Holger Hummerich; Janice Blevins; Pierluigi Gambetti; Inga Zerr; John Collinge; Simon Mead; Patrick F Chinnery
Journal:  Neurobiol Aging       Date:  2015-07-10       Impact factor: 4.673

7.  Cytosolic caspases mediate mislocalised SOD2 depletion in an in vitro model of chronic prion infection.

Authors:  Layla Sinclair; Victoria Lewis; Steven J Collins; Cathryn L Haigh
Journal:  Dis Model Mech       Date:  2013-04-04       Impact factor: 5.758

8.  Melatonin Protects Human Renal Proximal Tubule Epithelial Cells Against High Glucose-Mediated Fibrosis via the Cellular Prion Protein-TGF-β-Smad Signaling Axis.

Authors:  Yong-Seok Han; Yeo Min Yoon; Gyeongyun Go; Jun Hee Lee; Sang Hun Lee
Journal:  Int J Med Sci       Date:  2020-05-18       Impact factor: 3.738

Review 9.  The Link of the Prion Protein with Ca2+ Metabolism and ROS Production, and the Possible Implication in Aβ Toxicity.

Authors:  Agnese De Mario; Caterina Peggion; Maria Lina Massimino; Rosa Pia Norante; Alessandra Zulian; Alessandro Bertoli; Maria Catia Sorgato
Journal:  Int J Mol Sci       Date:  2019-09-19       Impact factor: 5.923

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.